Skip to main content

Table 2 Potential mutations in the ATM gene identified in Brazilian breast cancer patients

From: ATM gene mutations in sporadic breast cancer patients from Brazil

Exon position

Nucleotide change

Residue

Functional impact*

LOH

Sample

Age*** (years)

Clinical stage

13

c.1636C > G

p.L546V

Damaging

No

M227

46

I

14

c.1810C > T

p.P604S

Damaging

Yes**

M231

50

IV

20

c.2804C > G

p.T935R

Neutral

Yes**

M214

51

III

39

c.5647C > T

p.R1882X

Protein truncation

Yes**

M115

75

III

42

c.6067G > A

p.G2023R

Damaging

No

M294

45

II

49

c.6919C > T

p.L2307F

Damaging

No

72TL

67

II

Yes

M214

51

 

50

c.6995 T > C

p.L2332P

Neutral

Yes

112TL

25

II

No

M227

46

 
  1. http://chromium.liacs.nl/LOVD2/home.php?select_db=ATM (Last update January 2012); http://www.ncbi.nlm.nih.gov/projects/SNP/snp_ref.cgi?geneId=472;
  2. http://www.ensembl.org/Homo_sapiens/Gene/Variation_Gene/Table?db=core;g=ENSG00000149311;r=11:108093211–108239829; http://www.1000genomes.org/1000-genomes-browsers.
  3. *http://genetics.bwh.harvard.edu/pph2/; http://provean.jcvi.org/genome_submit_2.php.
  4. **LOH, indicates loss of the wild type allele.
  5. ***age at diagnosis.